Steigerwald, Gordon & Koch Inc. Stryker Corp Transaction History

Steigerwald, Gordon & Koch Inc.

$888 Million
Q1 2025

A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Stryker Corp stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 68,349 shares of SYK stock, worth $26.2 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares

68,349

Previous 69,282 1.35%

Holding current value

$26.2 Million

Previous $24.9 Million 2.0%

% of portfolio

2.86%

Previous 2.82%

54 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	SELL	$355.18 - $399.9 $331,382 - $373,106	-933 Reduced 1.35%	68,349 $25.4 Million
Q4 2024 Jan 16, 2025	SELL	$345.14 - $392.15 $328,918 - $373,718	-953 Reduced 1.36%	69,282 $24.9 Million
Q3 2024 Oct 09, 2024	BUY	$315.94 - $371.96 $352,273 - $414,735	1,115 Added 1.61%	70,235 $25.4 Million
Q2 2024 Aug 07, 2024	BUY	$324.3 - $354.67 $427,427 - $467,455	1,318 Added 1.94%	69,120 $23.5 Million
Q1 2024 Apr 16, 2024	BUY	$293.94 - $358.71 $142,854 - $174,333	486 Added 0.72%	67,802 $24.3 Million
Q4 2023 Jan 16, 2024	BUY	$253.85 - $299.46 $139,109 - $164,104	548 Added 0.82%	67,316 $20.2 Million
Q3 2023 Oct 11, 2023	BUY	$266.54 - $302.43 $114,878 - $130,347	431 Added 0.65%	66,768 $18.2 Million
Q2 2023 Jul 17, 2023	BUY	$271.49 - $305.09 $130,858 - $147,053	482 Added 0.73%	66,337 $20.2 Million
Q1 2023 Apr 19, 2023	BUY	$246.13 - $285.47 $152,354 - $176,705	619 Added 0.95%	65,855 $18.8 Million
Q4 2022 Jan 17, 2023	BUY	$205.51 - $253.93 $257,915 - $318,682	1,255 Added 1.96%	65,236 $0
Q3 2022 Oct 12, 2022	BUY	$189.27 - $231.83 $346,174 - $424,017	1,829 Added 2.94%	63,981 $13 Million
Q2 2022 Jul 14, 2022	BUY	$194.09 - $276.37 $179,921 - $256,194	927 Added 1.51%	62,152 $12.4 Million
Q1 2022 Apr 25, 2022	BUY	$245.33 - $277.77 $77,278 - $87,497	315 Added 0.52%	61,225 $16.4 Million
Q4 2021 Jan 26, 2022	BUY	$236.63 - $276.44 $333,411 - $389,503	1,409 Added 2.37%	60,910 $16.3 Million
Q3 2021 Oct 18, 2021	SELL	$248.9 - $280.09 $137,392 - $154,609	-552 Reduced 0.92%	59,501 $15.7 Million
Q2 2021 Jul 27, 2021	BUY	$242.95 - $267.0 $295,670 - $324,939	1,217 Added 2.07%	60,053 $15.6 Million
Q1 2021 Apr 27, 2021	SELL	$221.01 - $248.82 $59,893 - $67,430	-271 Reduced 0.46%	58,836 $14.3 Million
Q4 2020 Jan 22, 2021	BUY	$202.01 - $245.04 $74,339 - $90,174	368 Added 0.63%	59,107 $14.5 Million
Q3 2020 Oct 14, 2020	BUY	$177.77 - $215.81 $135,105 - $164,015	760 Added 1.31%	58,739 $12.2 Million
Q2 2020 Jul 14, 2020	BUY	$144.67 - $207.03 $160,439 - $229,596	1,109 Added 1.95%	57,979 $10.4 Million
Q1 2020 Apr 20, 2020	SELL	$126.5 - $225.1 $294,871 - $524,708	-2,331 Reduced 3.94%	56,870 $9.47 Million
Q4 2019 Jan 27, 2020	SELL	$197.98 - $220.53 $130,864 - $145,770	-661 Reduced 1.1%	59,201 $12.4 Million
Q3 2019 Oct 30, 2019	SELL	$205.4 - $221.82 $388,000 - $419,017	-1,889 Reduced 3.06%	59,862 $12.9 Million
Q2 2019 Jul 15, 2019	SELL	$180.24 - $205.58 $409,685 - $467,283	-2,273 Reduced 3.55%	61,751 $12.7 Million
Q1 2019 Apr 18, 2019	SELL	$152.46 - $198.0 $582,092 - $755,964	-3,818 Reduced 5.63%	64,024 $12.6 Million
Q4 2018 Jan 18, 2019	SELL	$145.0 - $178.65 $43,645 - $53,773	-301 Reduced 0.44%	67,842 $10.6 Million
Q3 2018 Oct 11, 2018	SELL	$163.25 - $177.68 $425,756 - $463,389	-2,608 Reduced 3.69%	68,143 $12.1 Million
Q2 2018 Sep 14, 2018	SELL	$155.17 - $179.78 $277,909 - $321,985	-1,791 Reduced 2.47%	70,751 $11.9 Million
Q1 2018 Sep 14, 2018	SELL	$148.01 - $168.91 $490,653 - $559,936	-3,315 Reduced 4.37%	72,542 $11.7 Million
Q4 2017 Sep 14, 2018	SELL	$143.51 - $159.74 $150,398 - $167,407	-1,048 Reduced 1.36%	75,857 $11.7 Million
Q3 2017 Sep 14, 2018	SELL	$138.36 - $147.87 $103,493 - $110,606	-748 Reduced 0.96%	76,905 $10.9 Million
Q2 2017 Sep 13, 2018	BUY	N/A	1,287 Added 1.69%	77,653 $10.7 Million
Q1 2017 Sep 13, 2018	BUY	N/A	1,727 Added 2.31%	76,366 $9.96 Million
Q4 2016 Sep 13, 2018	BUY	N/A	4,377 Added 6.23%	74,639 $8.82 Million
Q3 2016 Sep 13, 2018	SELL	N/A	-8,763 Reduced 11.09%	70,262 $8.06 Million
Q2 2016 Sep 13, 2018	BUY	N/A	1,597 Added 2.06%	79,025 $9.29 Million
Q1 2016 Sep 13, 2018	SELL	N/A	-395 Reduced 0.51%	77,428 $8.12 Million
Q4 2015 Sep 13, 2018	SELL	N/A	-1,287 Reduced 1.63%	77,823 $7.07 Million
Q3 2015 Sep 13, 2018	BUY	N/A	3,133 Added 4.12%	79,110 $7.28 Million
Q2 2015 Sep 13, 2018	BUY	N/A	138 Added 0.18%	75,977 $7.09 Million
Q1 2015 Sep 13, 2018	BUY	N/A	943 Added 1.26%	75,839 $6.83 Million
Q4 2014 Sep 13, 2018	BUY	N/A	202 Added 0.27%	74,896 $6.91 Million
Q3 2014 Sep 13, 2018	SELL	N/A	-1,442 Reduced 1.89%	74,694 $5.91 Million
Q2 2014 Sep 13, 2018	BUY	N/A	2,326 Added 3.15%	76,136 $6.29 Million
Q1 2014 Sep 13, 2018	BUY	N/A	1,358 Added 1.87%	73,810 $5.95 Million
Q4 2013 Sep 13, 2018	BUY	N/A	2,551 Added 3.65%	72,452 $5.39 Million
Q3 2013 Sep 13, 2018	BUY	N/A	3,876 Added 5.87%	69,901 $4.68 Million
Q2 2013 Sep 13, 2018	BUY	N/A	1,137 Added 1.75%	66,025 $4.23 Million
Q1 2013 Sep 13, 2018	BUY	N/A	3,801 Added 6.22%	64,888 $4.19 Million
Q4 2012 Sep 13, 2018	SELL	N/A	-473 Reduced 0.77%	61,087 $3.31 Million
Q3 2012 Sep 13, 2018	BUY	N/A	1,001 Added 1.65%	61,560 $3.39 Million
Q2 2012 Sep 13, 2018	BUY	N/A	6,502 Added 12.03%	60,559 $3.3 Million
Q1 2012 Sep 13, 2018	SELL	N/A	-249 Reduced 0.46%	54,057 $2.96 Million
Q4 2011 Sep 13, 2018	BUY	N/A	54,306	54,306 $2.67 Million

Others Institutions Holding SYK

# of Institutions

2,476

Shares Held

292M

Call Options Held

1.39M

Put Options Held

920K

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $145B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.

Account

Steigerwald, Gordon & Koch Inc. Stryker Corp Transaction History